The engines that powered Pontiac's LeMans came in a huge variety of displacements and power outputs throughout its history.

The iconic nameplate came to be as the Tempest LeMans (before getting promoted to a stand-alone series a year later), promising an upgraded experience behind the wheel with Pontiac's best four ...

LeMans is ready to leave for a new home; the car is almost in perfect shape, sporting a rare package and a big engine ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...

Note: This review specifically covers the single-player campaigns of Tempest Rising. For thoughts on multiplayer, stand by until after launch. It was only a matter of time before someone got tired ...

Tempest Rising is a polished, performant and brilliant real-time strategy (RTS) game powered by Unreal Engine 5. That's a sentence I never really expected to say just a few years ago, but a whole ...

Officials said they envision that the latest effort will invigorate the city. To rebuild downtown Pontiac, part of it is being torn down. City, county and state officials detailed plans Tuesday to ...

Tempest Therapeutics is charting rocky waters as it looks to secure a partner to advance its liver cancer drug through a Phase III trial. The US biotech’s clinical asset, amezalpat, has already ...

Washington — Pontiac Mayor Tim Greimel is joining a growing field of Democrats looking to reclaim a suburban Detroit congressional seat currently held by Republican U.S. Rep. John James.

Despite Pontiac's history of making cool looking, affordably priced cars, the company was not in great shape by the time that it was axed. It had suffered from years of underinvestment from GM and ...

BRISBANE, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated ...